Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function-Wan-Original Scan

The original western blot scans for the following manuscript: Wan L, Xu K, Wei Y, Zhang J, Han T, Fry C, Zhang Z, Wang YV, Huang L, Yuan M, Xia W, Chang WC, Huang WC, Liu CL, Chang YC, Liu J, Wu Y, Jin VX, Dai X, Guo J, Liu J, Jiang S, Li J, Asara JM, Brown M, Hung MC, Wei W. Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function. Mol Cell. 2018 Jan 18;69(2):279-291.e5. doi: 10.1016/j.molcel.2017.12.024. PubMed PMID: 29351847; PubMed Central PMCID: PMC5777296.本数据集为下述已发表论文的原始蛋白免疫印迹（western blot）扫描图像：作者包括Wan L、Xu K、Wei Y、Zhang J、Han T、Fry C、Zhang Z、Wang YV、Huang L、Yuan M、Xia W、Chang WC、Huang WC、Liu CL、Chang YC、Liu J、Wu Y、Jin VX、Dai X、Guo J、Liu J、Jiang S、Li J、Asara JM、Brown M、Hung MC、Wei W；论文标题为《AMPK（腺苷酸活化蛋白激酶）磷酸化EZH2（zeste基因增强子同源物2）抑制PRC2（多梳抑制复合体2）的甲基转移酶活性及致癌功能》，发表于《分子细胞（Mol Cell）》2018年1月18日，第69卷第2期，页码为279-291.e5；DOI：10.1016/j.molcel.2017.12.024；PubMed PMID：29351847；PubMed Central PMCID：PMC5777296。